Your browser doesn't support javascript.
loading
Polymerized porin as a novel delivery platform for coronavirus vaccine.
Yang, Zhongqian; Hua, Liangqun; Yang, Mengli; Li, Weiran; Ren, Zhaoling; Zheng, Xiao; Chen, Haoqian; Long, Qiong; Bai, Hongmei; Huang, Weiwei; Ma, Yanbing.
Afiliação
  • Yang Z; Laboratory of Molecular Immunology, Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, 650031, China.
  • Hua L; Laboratory of Molecular Immunology, Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, 650031, China.
  • Yang M; Yunnan University, Kunming, 650091, China.
  • Li W; National Kunming High-Level Biosafety Primate Research Center, Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, 650031, China.
  • Ren Z; Laboratory of Molecular Immunology, Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, 650031, China.
  • Zheng X; The Second Affiliated Hospital of Kunming Medical University, Kunming, 650033, China.
  • Chen H; Laboratory of Molecular Immunology, Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, 650031, China.
  • Long Q; Yunnan University, Kunming, 650091, China.
  • Bai H; Laboratory of Molecular Immunology, Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, 650031, China.
  • Huang W; Yunnan Minzu University, Kunming, 650504, China.
  • Ma Y; Laboratory of Molecular Immunology, Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, 650031, China.
J Nanobiotechnology ; 20(1): 260, 2022 Jun 07.
Article em En | MEDLINE | ID: mdl-35672856
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 Limite: Humans Idioma: En Revista: J Nanobiotechnology Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 Limite: Humans Idioma: En Revista: J Nanobiotechnology Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China